press releases

ST. HELIER, Jersey, Sept. 30, 2016 (GLOBE NEWSWIRE) — In a press release issued under the same headline earlier today by Novocure, Ltd. (Nasdaq:NVCR), please note that the first paragraph should say “the three and nine months ended Sept. 30, 2016” rather than “the three and six months ended Sept. Read More

ST. HELIER, Jersey, Sept. 30, 2016 (GLOBE NEWSWIRE) — In a press release issued under the same headline earlier today by Novocure, Ltd. (Nasdaq:NVCR), please note that the first paragraph should say “the three and nine months ended Sept. 30, 2016” rather than “the three and six months ended Sept. Read More

ST. HELIER, Jersey, Sept. 30, 2016 (GLOBE NEWSWIRE) — Novocure (NASDAQ:NVCR) announced today that it will report financial results for the third quarter 2016 on Wednesday, Nov. 2, 2016, before the open of U.S.-based financial markets. Novocure management will host a conference call and webcast to discuss its financial results… Read More

ST. HELIER, Jersey, Sept. 30, 2016 (GLOBE NEWSWIRE) — Novocure (NASDAQ:NVCR) announced today that it will report financial results for the third quarter 2016 on Wednesday, Nov. 2, 2016, before the open of U.S.-based financial markets. Novocure management will host a conference call and webcast to discuss its financial results… Read More

ST. HELIER, Jersey, Sept. 30, 2016 (GLOBE NEWSWIRE) — Novocure (NASDAQ:NVCR) announced today that it will report financial results for the third quarter 2016 on Wednesday, Nov. 2, 2016, before the open of U.S.-based financial markets. Novocure management will host a conference call and webcast to discuss its financial results… Read More

Guidelines provide a framework for using the NovoTAL System to optimize Tumor Treating Fields intensity in Optune patients Guidelines provide a framework for using the NovoTAL System to optimize Tumor Treating Fields intensity in Optune patients Tumor Treating Fields extend overall survival when combined… Read More

Guidelines provide a framework for using the NovoTAL System to optimize Tumor Treating Fields intensity in Optune patients Guidelines provide a framework for using the NovoTAL System to optimize Tumor Treating Fields intensity in Optune patients Tumor Treating Fields extend overall survival when combined… Read More

Guidelines provide a framework for using the NovoTAL System to optimize Tumor Treating Fields intensity in Optune patients Guidelines provide a framework for using the NovoTAL System to optimize Tumor Treating Fields intensity in Optune patients Tumor Treating Fields extend overall survival when combined… Read More

The NYAS’ 13th Key Symposium 2016: Bioelectronic Medicine – Technology Targeting Molecular Mechanisms brings together thought leaders to advance this growing frontier of patient care September 15, 2016 07:30 AM Eastern Daylight Time ST. HELIER, Jersey–(BUSINESS WIRE)–Novocure (NASDAQ:… Read More